| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Oryzon Genomics S.A (MC: ORY)
ORY Technical Analysis
5
| As on 7th Jul 2023 ORY STOCK Price closed @ 2.07 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.48 & Strong Sell for SHORT-TERM with Stoploss of 2.85 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ORYSTOCK Price
| Open | 2.07 | Change | Price | % |
| High | 2.08 | 1 Day | 0.01 | 0.49 |
| Low | 2.06 | 1 Week | -0.03 | -1.43 |
| Close | 2.07 | 1 Month | 0.02 | 0.98 |
| Volume | 38962 | 1 Year | -0.66 | -24.18 |
| 52 Week High 3.21 | 52 Week Low 2.04 | ||||
MC Spain Most Active Stocks
| UBS | 0.01 | 0.00% |
| DIA | 0.01 | 0.00% |
| SAN | 3.26 | 0.62% |
| SAB | 1.09 | 2.83% |
| IBE | 11.19 | -4.28% |
| TEF | 3.63 | -1.09% |
| UNI | 0.96 | 4.35% |
| BKY | 0.41 | 2.50% |
| BBVA | 6.89 | 0.73% |
| AI | 0.11 | 0.00% |
MC Spain Top Gainers Stocks
MC Spain Top Losers Stocks
| ORY Daily Charts |
ORY Intraday Charts |
Whats New @ Bazaartrend |
ORY Free Analysis |
|
|
ORY Important Levels Intraday
| RESISTANCE | 2.11 |
| RESISTANCE | 2.10 |
| RESISTANCE | 2.09 |
| RESISTANCE | 2.08 |
| SUPPORT | 2.06 |
| SUPPORT | 2.05 |
| SUPPORT | 2.04 |
| SUPPORT | 2.03 |
ORY Forecast May 2024
| 4th UP Forecast | 3.52 |
| 3rd UP Forecast | 3.05 |
| 2nd UP Forecast | 2.77 |
| 1st UP Forecast | 2.48 |
| 1st DOWN Forecast | 1.66 |
| 2nd DOWN Forecast | 1.37 |
| 3rd DOWN Forecast | 1.09 |
| 4th DOWN Forecast | 0.62 |
ORY Weekly Forecast
| 4th UP Forecast | 3.01 |
| 3rd UP Forecast | 2.71 |
| 2nd UP Forecast | 2.52 |
| 1st UP Forecast | 2.34 |
| 1st DOWN Forecast | 1.80 |
| 2nd DOWN Forecast | 1.62 |
| 3rd DOWN Forecast | 1.43 |
| 4th DOWN Forecast | 1.13 |
ORY Forecast2024
| 4th UP Forecast | 4.65 |
| 3rd UP Forecast | 3.82 |
| 2nd UP Forecast | 3.31 |
| 1st UP Forecast | 2.8 |
| 1st DOWN Forecast | 1.34 |
| 2nd DOWN Forecast | 0.83 |
| 3rd DOWN Forecast | 0.32 |
| 4th DOWN Forecast | -0.51 |
Oryzon Genomics S.A ( MC Spain Symbol : ORY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ORY Business Profile
Oryzon Genomics S.A., a clinical phase biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for the treatment of oncological and CNS disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, a LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases, as well as other programs at various stages of development. The company was founded in 2000 and is based in Cornellà de Llobregat, Spain. Address: Sant Ferran 74, Cornellà de Llobregat, Spain, 08940
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service